GGrantIndex
Sort

141,003 grants matching cytokine

Lipid and Lipoprotein Metabolism in Atherosclerosis

$3,670,549
Alan M Fogelman · University Of California Los Angeles · P01 · FY2006 · HL

MPN Research Consortium

$3,669,084
Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2022 · CA

Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)

$3,664,418
Estella M Alonso · Lurie Children'S Hospital Of Chicago · U01 · FY2021 · DK

Investigating Correlates and Therapeutics of Fatigue

$3,655,006
Leorey Saligan · National Institute Of Nursing Research · ZIA · FY2022 · NR

Multiscale Analysis of Immune Responses

$3,646,396
Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

The Contribution of Old Age-Associated Proteotoxicity to Inflammation and Dementia

$3,644,970
Pamela Anne Maher · Salk Institute For Biological Studies · RF1 · FY2017 · AG

Understanding Risk Gradients from Environment on Native American Child Health Trajectories: Toxicants, Immunomodulation, Metabolic syndromes, & Metals Exposure

$3,641,961
Johnnye L Lewis · University Of New Mexico Health Scis Ctr · UG3 · FY2017 · OD

A Multi-Center Group to Study Acute Liver Failure in Children

$3,638,432
Robert H Squires · University Of Pittsburgh At Pittsburgh · U01 · FY2011 · DK

A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease

$3,638,367
Stacey Lynn Clardy · University Of Utah · U01 · FY2024 · NS

Systemic Autoimmunity

$3,637,839
Mariana Kaplan · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2025 · AR

Metabolic and epigenetic reprogramming of vital organs in SARS-CoV-2 induced systemic toxicity

$3,636,473
Arjun Deb · University Of California Los Angeles · R01 · FY2021 · DK

Obesity, Body Fat Distribution, and Cancer Risk in the Multiethnic Cohort

$3,632,670
Loic Le Marchand · University Of Hawaii At Manoa · P01 · FY2012 · CA

Recipient Epidemiology and Donor Evaluation Study III (REDS-III) Central Lab

$3,624,423
Michael Busch · Vitalant · N01 · FY2014 · HL

Pathogenic Mechanisms in Spondyloarthritis

$3,621,719
Robert Colbert · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2016 · AR

Targeting the NLRP3 Inflammasome to Mitigate Neuroinflammation and HIV Persistence in the CNS: Mechanisms and Therapeutic Strategies

$3,613,504
Talia H Swartz · Icahn School Of Medicine At Mount Sinai · RF1 · FY2025 · MH

Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS

$3,608,886
Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA

Gene Transfer And Ex Vivo Manipulation Of Hematopoietic Cells

$3,605,498
Cynthia E Dunbar · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL

UNM Metals Exposure and Toxicity Assessment on tribal Lands in the Southwest (METALS) Superfund Research Program

$3,597,804
Jose Manuel Cerrato · University Of New Mexico Health Scis Ctr · P42 · FY2025 · ES

Studies of Inherited Causes of Fungal Susceptability

$3,597,410
Sergio Rosenzweig · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

Post-Irradiation Intervention to Mitigate and Treat Non Hematological Radiation

$3,594,363
John E Moulder · Medical College Of Wisconsin · U19 · FY2008 · AI

Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina

$3,591,502
Rachel R. Caspi · National Eye Institute · ZIA · FY2018 · EY

Lipid and Lipoprotein Metabolism in Atherosclerosis

$3,584,797
University Of California Los Angeles · P01 · FY2005 · HL

Post-Irradiation Intervention to Mitigate and Treat Non Hematological Radiation

$3,583,641
John E Moulder · Medical College Of Wisconsin · U19 · FY2007 · AI

Pathogenic Mechanisms in Spondyloarthritis

$3,582,224
Robert Colbert · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2017 · AR

Strategies for Cancer Immunotherapy Development: Preclinical Studies

$3,580,727
Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA